Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

2,336 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?
Simes RJ, Marschner IC, Hunt D, Colquhoun D, Sullivan D, Stewart RA, Hague W, Keech A, Thompson P, White H, Shaw J, Tonkin A; LIPID Study Investigators. Simes RJ, et al. Among authors: sullivan d. Circulation. 2002 Mar 12;105(10):1162-9. doi: 10.1161/hc1002.105136. Circulation. 2002. PMID: 11889008
Lipid-modifying drugs.
Simons LA, Sullivan DR. Simons LA, et al. Med J Aust. 2005 Mar 21;182(6):286-9. doi: 10.5694/j.1326-5377.2005.tb06703.x. Med J Aust. 2005. PMID: 15777144 Review.
Neither plasma coenzyme Q10 concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: a prospective case-control study from the LIPID study.
Stocker R, Pollicino C, Gay CA, Nestel P, Colquhoun D, Whiting M, Tonkin A, Sullivan D, Simes J. Stocker R, et al. Among authors: sullivan d. Atherosclerosis. 2006 Jul;187(1):198-204. doi: 10.1016/j.atherosclerosis.2005.09.004. Epub 2005 Oct 10. Atherosclerosis. 2006. PMID: 16219312
2,336 results